Swallowable device to detect Barrett's esophagus receives FDA 510(k) clearance

by Case Western Reserve University"FDA clearance of the EsoCheck device means the device is now available to patients and physicians as a non-endoscopic method for sampling the esophagus. Th

Updated on: May 09,2024

Swallowable device to detect Barrett's esophagus receives FDA 510(k) clearance

by Case Western Reserve University"FDA clearance of the EsoCheck device means the device is now available to patients and physicians as a non-endoscopic method for sampling the esophagus. Th

Updated on:May 09,2024

Promising new pancreatic cancer treatment moves forward

by Huntsman Cancer InstituteCredit: CC0 Public DomainEven among cancers, pancreatic cancer is an especially sinister form of disease. The one-year survival rate is extremely low, and treatment progres

Updated on: May 07,2024

Promising new pancreatic cancer treatment moves forward

by Huntsman Cancer InstituteCredit: CC0 Public DomainEven among cancers, pancreatic cancer is an especially sinister form of disease. The one-year survival rate is extremely low, and treatment progres

Updated on:May 07,2024

New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

byKing's College LondonUCART19 cellular kinetics and correlation with clinical response. A, Graphical representation of UCART19 kinetic profile in PB of patients with B-ALL in the CALM study

Updated on: January 11,2024

New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

byKing's College LondonUCART19 cellular kinetics and correlation with clinical response. A, Graphical representation of UCART19 kinetic profile in PB of patients with B-ALL in the CALM study

Updated on:January 11,2024

Cytometry chip supports new revolution in cancer care for a truly personalized treatment plan

by IMECImec's cell sorter concept uses integrated star-shaped microheaters to push the target cells into a side channel. Credit: IMECImec teamed up with the KU Leuven laboratory of tumor immu

Updated on: March 05,2024

Cytometry chip supports new revolution in cancer care for a truly personalized treatment plan

by IMECImec's cell sorter concept uses integrated star-shaped microheaters to push the target cells into a side channel. Credit: IMECImec teamed up with the KU Leuven laboratory of tumor immu

Updated on:March 05,2024

Study suggests lung cancer does not decrease in line with reduced smoking

byUmea UniversityIncidence rates for lung cancer according to age, sex and time (cases/100,000 person-years). Notice the different scales on the vertical axes (incidence rates). Credit:Eur

Updated on: April 06,2024

Study suggests lung cancer does not decrease in line with reduced smoking

byUmea UniversityIncidence rates for lung cancer according to age, sex and time (cases/100,000 person-years). Notice the different scales on the vertical axes (incidence rates). Credit:Eur

Updated on:April 06,2024

Liquid biopsy as effective as tissue biopsy for non-small cell lung cancer: study

by University of Texas M. D. Anderson Cancer CenterVassiliki Papadimitrakopoulou, M.D. Credit: MD Anderson Cancer CenterA multi-center study led by researchers at The University of Texas MD Ander

Updated on: May 23,2024

Liquid biopsy as effective as tissue biopsy for non-small cell lung cancer: study

by University of Texas M. D. Anderson Cancer CenterVassiliki Papadimitrakopoulou, M.D. Credit: MD Anderson Cancer CenterA multi-center study led by researchers at The University of Texas MD Ander

Updated on:May 23,2024

Cancer mortality higher among American Indian and Alaska Native individuals; colorectal cancer before age 50 rising

byAmerican Cancer SocietyResearchers at the American Cancer Society stress improving access to high-quality cancer prevention, early detection, and treatment for this group of individuals. Credi

Updated on: January 02,2024

Cancer mortality higher among American Indian and Alaska Native individuals; colorectal cancer before age 50 rising

byAmerican Cancer SocietyResearchers at the American Cancer Society stress improving access to high-quality cancer prevention, early detection, and treatment for this group of individuals. Credi

Updated on:January 02,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on: September 27,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on:September 27,2024

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos

Updated on: December 01,2024

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos

Updated on:December 01,2024

Unique genetic signature found by research in different types of cancer

by MELISA InstitutetimsTOF Pro mass spectrometer located in MELISA Institute's laboratories. Credit: MELISA InstituteResearch led by Dr. Mabel Vidal in the Department of Computer Science at the Un

Updated on: January 07,2024

Unique genetic signature found by research in different types of cancer

by MELISA InstitutetimsTOF Pro mass spectrometer located in MELISA Institute's laboratories. Credit: MELISA InstituteResearch led by Dr. Mabel Vidal in the Department of Computer Science at the Un

Updated on:January 07,2024

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Updated on: January 04,2024

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Updated on:January 04,2024

New method reveals insights into interplay between immune system and tumors

by Mallory Locklear,Yale UniversitySingle cell genomics reveals multiple human immune cell types in tumors and blood of autologous MISTRG6 PDX mice, including innate immune cell types present in

Updated on: January 13,2024

New method reveals insights into interplay between immune system and tumors

by Mallory Locklear,Yale UniversitySingle cell genomics reveals multiple human immune cell types in tumors and blood of autologous MISTRG6 PDX mice, including innate immune cell types present in

Updated on:January 13,2024